{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:39:34Z","timestamp":1792784374066,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Tianshan Talents Project of the Xinjiang Uygur Autonomous Region","award":["2022TSYCLJ009"],"award-info":[{"award-number":["2022TSYCLJ009"]}]},{"name":"Tianshan Talents Project of the Xinjiang Uygur Autonomous Region","award":["2022TSYCCX0021"],"award-info":[{"award-number":["2022TSYCCX0021"]}]},{"name":"The key program of the Xinjiang Uygur Autonomous Region"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100942"],"award-info":[{"award-number":["32100942"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.phymed.2025.156486","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:33:21Z","timestamp":1749209601000},"page":"156486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Apigenin suppresses keratinocyte hyperproliferation and inflammation in psoriasis by inhibiting CDK2\/E2F2 pathway"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0527-2154","authenticated-orcid":false,"given":"Abudureyimu","family":"Alimujiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9502-0543","authenticated-orcid":false,"given":"Dengqiu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.phymed.2025.156486_bib0001","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMa"},{"issue":"24","key":"10.1016\/j.phymed.2025.156486_bib0002","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1038\/sj.emboj.7600481","article-title":"The E2F family: specific functions and overlapping interests","volume":"23","author":"Attwooll","year":"2004","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.phymed.2025.156486_bib0003","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.05.036","article-title":"Infliximab induces downregulation of the IL-12\/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages","volume":"132","author":"Brunner","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.phymed.2025.156486_bib0004","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.phymed.2025.156486_bib0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1535-6108(03)00080-1","article-title":"Emerging roles for E2F-beyond the G1-S transition and DNA replication","volume":"3","author":"Cam","year":"2003","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.phymed.2025.156486_bib0006","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.immuni.2011.09.010","article-title":"Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E","volume":"35","author":"Chang","year":"2011","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.phymed.2025.156486_bib0007","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","article-title":"The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis","volume":"19","author":"Dainichi","year":"2018","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.phymed.2025.156486_bib0008","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T cell responses in psoriasis and psoriatic arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.phymed.2025.156486_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010251","article-title":"Resources for Human health from the plant Kingdom: the potential role of the flavonoid apigenin in cancer counteraction","volume":"25","author":"Fossatelli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phymed.2025.156486_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jdermsci.2012.06.008","article-title":"Keratin 17 as a therapeutic target for the treatment of psoriasis","volume":"67","author":"Fu","year":"2012","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.phymed.2025.156486_bib0011","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and keratinocytes in psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2025.156486_bib0012","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaad.2016.07.058","article-title":"Secukinumab shows significant efficacy in palmoplantar psoriasis: results from GESTURE, a randomized controlled trial","volume":"76","author":"Gottlieb","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phymed.2025.156486_bib0013","first-page":"1301","volume":"397","author":"Griffiths","year":"2021"},{"issue":"33","key":"10.1016\/j.phymed.2025.156486_bib0014","doi-asserted-by":"crossref","first-page":"E3422","DOI":"10.1073\/pnas.1400513111","article-title":"IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms","volume":"111","author":"Ha","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"41","key":"10.1016\/j.phymed.2025.156486_bib0015","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1038\/onc.2010.296","article-title":"Accelerated DNA replication in E2F1- and E2F2-deficient macrophages leads to induction of the DNA damage response and p21(CIP1)-dependent senescence","volume":"29","author":"Iglesias-Ara","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.phymed.2025.156486_bib0016","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.apsb.2019.11.006","article-title":"A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models","volume":"10","author":"Jin","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.phymed.2025.156486_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tcb.2009.01.002","article-title":"Atypical E2Fs: new players in the E2F transcription factor family","volume":"19","author":"Lammens","year":"2009","journal-title":"Trends. Cell Biol."},{"issue":"4","key":"10.1016\/j.phymed.2025.156486_bib0018","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2133.1995.tb02696.x","article-title":"Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro","volume":"133","author":"Leigh","year":"1995","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.phymed.2025.156486_bib0019","first-page":"1468","article-title":"Efficacy and safety of Calcipotriene plus betamethasone dipropionate aerosol foam in patients with psoriasis Vulgaris\u2013a randomized phase III study (PSO-FAST)","volume":"14","author":"Leonardi","year":"2015","journal-title":"J. Drugs Dermatol."},{"issue":"2","key":"10.1016\/j.phymed.2025.156486_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5582\/bst.2021.01072","article-title":"The E2F transcription factor 2: what do we know?","volume":"15","author":"Li","year":"2021","journal-title":"Biosci. Trends."},{"issue":"10","key":"10.1016\/j.phymed.2025.156486_bib0021","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.phymed.2025.156486_bib0022","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.apsb.2020.11.008","article-title":"Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model","volume":"11","author":"Lin","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phymed.2025.156486_bib0023","article-title":"Apigenin inhibits the histamine-induced proliferation of ovarian cancer cells by downregulating ERalpha\/ERbeta expression","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phymed.2025.156486_bib0024","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156486_bib0025","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41467-023-39020-4","article-title":"Single cell and spatial sequencing define processes by which keratinocytes and fibroblasts amplify inflammatory responses in psoriasis","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phymed.2025.156486_bib0026","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 Family of Cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phymed.2025.156486_bib0027","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.phymed.2025.156486_bib0028","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2133.2000.03826.x","article-title":"Cyclin D1, B and A expression and cell turnover in psoriatic skin lesions before and after cyclosporin treatment","volume":"143","author":"Miracco","year":"2000","journal-title":"Br. J. Dermatol."},{"issue":"11","key":"10.1016\/j.phymed.2025.156486_bib0029","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1172\/JCI134217","article-title":"The CDK4\/6-EZH2 pathway is a potential therapeutic target for psoriasis","volume":"130","author":"Muller","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phymed.2025.156486_bib0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phymed.2025.156486_bib0031","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","article-title":"Keratinocyte: a trigger or an executor of psoriasis?","volume":"108","author":"Ni","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.phymed.2025.156486_bib0032","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"19","key":"10.1016\/j.phymed.2025.156486_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910841","article-title":"Skin barrier dysregulation in psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.phymed.2025.156486_bib0034","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/ijms19071822","article-title":"Decryption of active constituents and action mechanism of the traditional uighur prescription (BXXTR) alleviating IMQ-induced psoriasis-like skin inflammation in BALB\/c mice","volume":"19","author":"Pang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2025.156486_bib0035","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.phymed.2025.156486_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phymed.2025.156486_bib0037","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jdermsci.2010.05.002","article-title":"Regulation of epidermal keratinocytes by growth factors","volume":"59","author":"Shirakata","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.phymed.2025.156486_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121909","article-title":"Anti-inflammatory, anti-proliferative and anti-psoriatic potential of apigenin in RAW 264.7 cells, HaCaT cells and psoriasis like dermatitis in BALB\/c mice","volume":"328","author":"Singh","year":"2023","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.phymed.2025.156486_bib0039","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41419-023-06342-6","article-title":"Transcriptome reprogramming through alternative splicing triggered by apigenin drives cell death in triple-negative breast cancer","volume":"14","author":"Sudhakaran","year":"2023","journal-title":"Cell Death. Dis."},{"issue":"6","key":"10.1016\/j.phymed.2025.156486_bib0040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/mol.112.077735","article-title":"Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth","volume":"81","author":"Tan","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2025.156486_bib0041","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2025.156486_bib0042","series-title":"Global Report on Psoriasis","year":"2016"},{"key":"10.1016\/j.phymed.2025.156486_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111308","article-title":"Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation","volume":"137","author":"Wu","year":"2021","journal-title":"Biomed. PharmacOther"},{"issue":"1","key":"10.1016\/j.phymed.2025.156486_bib0044","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.apsb.2021.07.019","article-title":"Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment","volume":"12","author":"Xi","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.phymed.2025.156486_bib0045","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.jid.2017.05.015","article-title":"Nrf2 Promotes keratinocyte proliferation in psoriasis through up-regulation of keratin 6, keratin 16, and keratin 17","volume":"137","author":"Yang","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.phymed.2025.156486_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021498","article-title":"Apigenin: a therapeutic agent for treatment of skin inflammatory diseases and cancer","volume":"24","author":"Yoon","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.phymed.2025.156486_bib0047","first-page":"5193","article-title":"Quantitative identification of Q-markers of Euphorbiae Humifusae Herba based on AHP-CRITIC comprehensive weighting method","volume":"47","author":"Zeng","year":"2022","journal-title":"Zhongguo Zhong. Yao Za Zhi."},{"key":"10.1016\/j.phymed.2025.156486_bib0048","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yjmcc.2013.04.009","article-title":"Contrasting roles of E2F2 and E2F3 in endothelial cell growth and ischemic angiogenesis","volume":"60","author":"Zhou","year":"2013","journal-title":"J. Mol. Cell Cardiol."},{"issue":"6","key":"10.1016\/j.phymed.2025.156486_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065755","article-title":"Contrasting roles of E2F2 and E2F3 in cardiac neovascularization","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.phymed.2025.156486_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death. Dis."},{"issue":"Pt A","key":"10.1016\/j.phymed.2025.156486_bib0051","article-title":"Qingre Lishi Decoction ameliorates imiquimod-induced psoriasis-like skin lesions in SKH-1 mice by regulating the Treg-DC-Th17 axis and inhibiting MAPK-mediated DC maturation","volume":"318","author":"Zhu","year":"2024","journal-title":"J. Ethnopharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:49:19Z","timestamp":1762332559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"alternative-id":["S0944711325001278"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156486","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apigenin suppresses keratinocyte hyperproliferation and inflammation in psoriasis by inhibiting CDK2\/E2F2 pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156486"}}